-
Chapter and Conference Paper
Combination of 5-FU, Leucovorin and Cisplatin (CDDP): an efficient low-toxic chemotherapy in advanced gastric adenocarcinoma
Metastatic gastric cancer remains a frequent disease with spontaneous median survival of about 6 months [1]. FAM regimen (5-FU, Doxorubicin and Mitomycin) was until the nineteens, considered as standard treatm...
-
Article
High-dose, single-agent irinotecan as first-line therapy in the treatment of metastatic colorectal cancer
Abstract
-
Article
Tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastases
To assess the rate of R0 resection of liver metastases achieved after chemotherapy with FOLFIRINOX.
-
Article
Feasibility of biweekly combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in patients with metastatic solid tumors: results of a two-step phase I trial: XELIRI and XELIRINOX
Biweekly schedule of capecitabine combined with irinotecan (XELIRI), consecutively with irinotecan and oxaliplatin (XELIRINOX), was evaluated in patients with metastatic cancer from any solid tumors.